Creabilis Raises $20M To Develop Dermatology Drugs
European biotechnology company Creabilis SA said Tuesday it raised €15 million ($20 million) in funding led by Abbott Biotech Ventures Inc. to pay for the continued development of its most important drug...To view the full article, register now.
Already a subscriber? Click here to view full article